Health Canada inspection
HRA Pharma Rare Disease: Health Canada inspection of Oct 16, 2023
Health Canada · GVP · rating C
Key facts
| Establishment | HRA Pharma Rare Disease |
|---|---|
| City | Chatillon |
| Province | Hauts-De-Seine |
| Country | France |
| Program | GVP |
| Start date | Oct 10, 2023 |
| End date | Oct 16, 2023 |
| Rating | C |
| Rating description | Compliant |
At a glance
- 1–9 Observations cited
- 1–9 Inspections of this establishment
- No Currently licensed
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Health Canada inspections
Health Canada inspects establishments that conduct licensable activities with drugs, including good manufacturing practices (GMP) and pharmacovigilance (GVP) inspections. Clinical trial (GCP) inspections, which name individuals, are not published here.
Source: Health Canada, Drug and Health Product Inspections. Contains information licensed under the Open Government Licence – Canada · Source date: